300289SZSE
🚨 Material Event

Announcement on Resolutions of the 12th Meeting of the 6th Board of Directors

Lideman Co., Ltd.··18 pages

✨ AI Summary

Beijing Leaderbio Co., Ltd. held its 12th Board meeting, approving the establishment of a remuneration management system for directors and senior management, and amendments to the company's articles of association. The board also approved a major asset purchase plan, involving the acquisition of 61.50% of Beijing Sinovac Pharmaceutical Co., Ltd. for RMB 139,297.50 million.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Beijing Leaderbio Co., Ltd.

Announcement on Resolutions of the 12th Meeting of the 6th Board of Directors

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, without false records, misleading statements, or material omissions.

The 12th meeting of the 6th Board of Directors of Beijing Leaderbio Co., Ltd. (hereinafter referred to as the "Company") was held via communication on June 12, 2026, in the second-floor conference room at Xinghai Road No. 5, Beijing Economic-Technological Development Area, Beijing. The notice of this meeting was sent to all directors via email on June 4, 2026. All attending directors have been informed of the necessary information related to the matters to be deliberated. The meeting was chaired by Ms. Yao Zi, Chairperson. Seven directors were required to attend, and seven directors personally attended. All senior management personnel of the Company were present at the meeting. The convening and holding of this meeting comply with the "Company Law," "Articles of Association," and other relevant regulations. The resolutions formed at the meeting are legal and valid. After deliberation by all directors, the following proposal was approved by written vote:

I. Proposal on the Formulation of the "Remuneration Management System for Directors and Senior Management of Beijing Leaderbio Co., Ltd."

Approved the formulation of the "Remuneration Management System for Directors and Senior Management of Beijing Leaderbio Co., Ltd." by the Company in accordance with the "Code of Corporate Governance for Listed Companies," "Articles of Association," and the Company's actual situation.

This proposal has been reviewed and approved by the Remuneration and Appraisal Committee of the Company.

Voting results: 7 votes in favor, 0 votes against, 0 abstentions.

For details, please refer to the "Remuneration Management System for Directors and Senior Management of Beijing Leaderbio Co., Ltd." disclosed by the Company on the CNINFO website (http://www.cninfo.com.cn).

This proposal needs to be submitted to the shareholders' meeting for deliberation.

II. Proposal on the Amendment to the "Articles of Association"

In accordance with the "Company Law," "Constitution of the Communist Party of China," and the "Regulations on the Work of Grassroots Organizations of State-Owned Enterprises of the Communist Party of China (Trial)," and other relevant regulations, to further implement and improve the requirements for Party building work, protect the legitimate rights and interests of the Company and shareholders, and based on the actual situation, the Company proposes to amend the "Articles of Association" regarding Party building work.

It is agreed to submit this proposal to the first extraordinary general meeting of shareholders of the Company in 2026 for deliberation and approval by special resolution. At the same time, the Company requests the shareholders' meeting to authorize the Chairperson and their authorized personnel to handle the industrial and commercial registration, filing, and other related matters concerning the amendment of the "Articles of Association." The Chairperson and their authorized personnel are also authorized to make necessary modifications to the relevant clauses of the amended "Articles of Association" based on the approval opinions or requirements of the market supervision department or other government departments. The final content of the amendment to the relevant clauses of the "Articles of Association" will be subject to the approval of the market supervision department.

For details, please refer to the "Announcement on the Amendment to the Articles of Association" (Announcement No.: 2026-035) and the "Articles of Association of Beijing Leaderbio Co., Ltd." (June 2026) disclosed by the Company on the CNINFO website (http://www.cninfo.com.cn).

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.